Comments
Loading...
Cara Therapeutics (CARA) Forecast
NewsEarningsCara Therapeutics (CARA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCara Therapeutics (NASDAQ:CARA) Stock Quotes, Forecast and News Summary
Cara Therapeutics Stock (NASDAQ: CARA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cara Therapeutics (CARA) stock?
You can purchase shares of Cara Therapeutics (NASDAQ:CARA) through any online brokerage.
Who are Cara Therapeutics (CARA) competitors?
Other companies in Cara Therapeutics’s space includes: Cingulate (NASDAQ:CING), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP), CalciMedica (NASDAQ:CALC) and Lipocine (NASDAQ:LPCN).
What is the forecast, or price target, for Cara Therapeutics (CARA) stock?
Cara Therapeutics has a consensus price target of $12.57.
What is the current price for Cara Therapeutics (CARA)?
The stock price for Cara Therapeutics (NASDAQ: CARA) is $5.13 last updated February 21, 2025 at 10:28 AM EST.
Does Cara Therapeutics (CARA) pay a dividend?
There are no upcoming dividends for Cara Therapeutics.
When is Cara Therapeutics (NASDAQ:CARA) reporting earnings?
Cara Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.
Is Cara Therapeutics (CARA) going to split?
There is no upcoming split for Cara Therapeutics.
What sector and industry does Cara Therapeutics (CARA) operate in?
Cara Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.